Labcorp (NYSE:LH – Get Free Report) and Agilon Health (NYSE:AGL – Get Free Report) are both healthcare companies, but which is the better business? We will compare the two companies based on the strength of their dividends, institutional ownership, profitability, earnings, analyst recommendations, valuation and risk.
Insider & Institutional Ownership
95.9% of Labcorp shares are owned by institutional investors. 0.8% of Labcorp shares are owned by insiders. Comparatively, 2.5% of Agilon Health shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Profitability
This table compares Labcorp and Agilon Health’s net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Labcorp | 6.99% | 16.74% | 7.81% |
| Agilon Health | -3.92% | -122.70% | -17.24% |
Valuation and Earnings
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| Labcorp | $13.95 billion | 1.86 | $876.50 million | $12.09 | 26.21 |
| Agilon Health | $5.93 billion | 0.24 | -$391.35 million | ($21.56) | -4.03 |
Labcorp has higher revenue and earnings than Agilon Health. Agilon Health is trading at a lower price-to-earnings ratio than Labcorp, indicating that it is currently the more affordable of the two stocks.
Risk and Volatility
Labcorp has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500. Comparatively, Agilon Health has a beta of 3.01, suggesting that its stock price is 201% more volatile than the S&P 500.
Analyst Ratings
This is a breakdown of current ratings and recommmendations for Labcorp and Agilon Health, as provided by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Labcorp | 0 | 3 | 9 | 0 | 2.75 |
| Agilon Health | 3 | 7 | 5 | 0 | 2.13 |
Labcorp presently has a consensus price target of $326.82, suggesting a potential upside of 3.12%. Agilon Health has a consensus price target of $84.82, suggesting a potential downside of 2.44%. Given Labcorp’s stronger consensus rating and higher probable upside, equities analysts clearly believe Labcorp is more favorable than Agilon Health.
Summary
Labcorp beats Agilon Health on 12 of the 14 factors compared between the two stocks.
About Labcorp
Labcorp Holdings, Inc. engages in providing medical testing services. The company was founded on April 16, 2024 and is headquartered in Burlington, NC.
About Agilon Health
agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc. and changed its name to agilon health, inc. in March 2021. agilon health, inc. was founded in 2016 and is based in Austin, Texas.
Receive News & Ratings for Labcorp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Labcorp and related companies with MarketBeat.com's FREE daily email newsletter.
